Hormonal
Increased intake of starchy vegetables, specifically potatoes, corn, and peas, is positively associated with weight gain, contrasting with non-starchy vegetables.
Be mindful of starchy vegetables like potatoes, corn, and peas. Unlike leafy greens or broccoli, increasing your intake of these specific vegetables is linked to weight gain, likely due to their higher glycemic load. Balance your plate with non-starchy vegetables and moderate portions of starchy ones.
On the other hand, increased intake of starchy vegetables, including corn, peas, and potatoes, was associated with weight gain... additional daily servings of baked, boiled or mashed potatoes (0.74 lb; 95% CI 0.19 to 1.30 lb), peas (1.13 lb; 95% CI 0.37 to 1.89 lb), or corn (2.04 lb; 95% CI 0.94 to 3.15 lb) were each positively associated with weight change.
Why this rating
Same high-quality cohort data as N1, with specific subgroup analysis.
Source
Changes in Intake of Fruits and Vegetables and Weight Change in United States Men and Women Followed for Up to 24 Years: Analysis from Three Prospective Cohort Studies
Monica L. Bertoia et al. · PLoS Medicine · 2015
DOI 10.1371/journal.pmed.1001878
More from this paper
- Increased consumption of non-starchy fruits and vegetables is inversely associated with weight gain, with specific subtypes like berries, apples/pears, cruciferous, and green leafy vegetables showing the strongest protective effects against weight change.Good
- Higher fiber and lower glycemic load (GL) in vegetables are associated with stronger inverse relationships with weight change, whereas fiber and GL content in fruits do not significantly modify the weight loss association.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →